Silymarin

This product is a drug for the treatment of liver disease. Pharmacology: It has been shown that in various toxic liver damage pathological models, silymarin can neutralize poisoning caused by muscimol, α-amanitin (a toxic substance found in the Amanita phalloides fungus), carbon tetrachloride, galactosamine, thioacetamide and hepatovirus FV3. The therapeutic effect of silymarin is attributed to its several points of action and mechanisms of action: due to its ability to capture free radicals, silymarin has antioxidant activity. The pathophysiological process of lipid peroxidation (causing damage to cell membranes) can be interrupted or prevented by silymarin. And in already damaged liver cells, silymarin stimulates protein synthesis and normalizes phospholipid metabolism. In short, the greatest contribution of silymarin is its stabilizing effect on liver cell membranes, which prevents or avoids dissolution.

The main ingredient of this product and its chemical name is: silymarin.

It is suitable for chronic hepatitis, liver fibrosis and cirrhosis, fatty liver, alcoholic liver, and toxic liver damage; it has a good preventive effect on fatty liver, alcoholic liver and drug-induced liver damage.

Patients with severe liver disease should take 420 mg per day, divided into three times before meals; the maintenance dose for patients with moderate liver disease is 280 mg per day, divided into two times before meals; the preventive dose is 140 mg per day, taken once a day before meals.

Mild diarrhea occurred in individual cases.

Not yet clear

Store in a cool, dry place.

API

Five years

Hunan Qianjin Xieli Pharmaceutical Co., Ltd.

• Founded in:

  2003-06-26

• Address:

  No. 1361, Huanghe North Road, Tianyuan District, Zhuzhou City

• Tax NO.:

  9143020075336479XF

• Registered Funds:

  32 million yuan

• Website:

  Log in to view

• Email:

  Log in to view